tabimorelin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2009
0120002009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Time-dependent inhibition (TDI) of cytochrome P450 (P450) enzymes caused by new molecular entities (NMEs) is of concern because… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2004
2004
OBJECTIVE The aim was to investigate the possible interactions of the two peripheral hormones, leptin and ghrelin, that regulate… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2003
2003
Objective. NN703 (tabimorelin) is an orally active growth hormone (GH) secretagogue intended for use as an alternative to daily… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
2001
2001
The aim of the present study was to assess the safety, pharmacokinetics and pharmacodynamics (including specificity) of NN703… (More)
Is this relevant?
2000
2000
The aim of the present study was to investigate the pharmacodynamics, pharmacokinetics, safety and tolerability of a single dose… (More)
Is this relevant?